New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New Insights in Cushing Disease Treatment With Focus on a Derivative of Vitamin A
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-24
DOI
10.3389/fendo.2018.00262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
- (2018) André Lacroix et al. Lancet Diabetes & Endocrinology
- Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases
- (2017) Joseph L. Napoli PHARMACOLOGY & THERAPEUTICS
- Role of tyrosine kinase inhibitors in the treatment of pituitary tumours
- (2017) Anat Ben-Shlomo et al. Current Opinion in Endocrinology Diabetes and Obesity
- Vitamin A, endocrine tissues and hormones: interplay and interactions
- (2017) J Brossaud et al. Endocrine Connections
- BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas
- (2017) Alejandro Ibáñez-Costa et al. Scientific Reports
- Cabergoline for Cushing’s disease: a large retrospective multicenter study
- (2016) A Ferriere et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effect of retinoic acid on human adrenal corticosteroid synthesis
- (2016) Antonella Sesta et al. LIFE SCIENCES
- Updates on the role of adrenal steroidogenesis inhibitors in Cushing’s syndrome: a focus on novel therapies
- (2016) Maria Fleseriu et al. Pituitary
- The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
- (2016) Lucio Vilar et al. International Journal of Endocrinology
- The Treatment of Cushing's Disease
- (2015) Rosario Pivonello et al. ENDOCRINE REVIEWS
- Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients
- (2015) P. Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- THERAPY OF ENDOCRINE DISEASE: Steroidogenesis enzyme inhibitors in Cushing's syndrome
- (2015) E. Daniel et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Emerging drugs for Cushing’s disease
- (2015) Daniela Guelho et al. EXPERT OPINION ON EMERGING DRUGS
- Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
- (2015) Lynnette K. Nieman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
- (2015) Eleni Daniel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease
- (2015) Ning-Ai Liu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The role of temozolomide in the treatment of aggressive pituitary tumors
- (2015) James K. Liu et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
- (2015) Maria Fleseriu et al. Pituitary
- Clinical use of pasireotide for Cushing's disease in adults
- (2015) Marco Boscaro et al. Therapeutics and Clinical Risk Management
- Retinoic acid receptor-^|^alpha; up-regulates proopiomelanocortin gene expression in AtT20 corticotroph cells
- (2014) Akira Uruno et al. ENDOCRINE JOURNAL
- Cushing Disease: Highlighting the Importance of Early Diagnosis for Both de Novo and Recurrent Disease in Light of Evolving Treatment Patterns
- (2014) Elizabeth Lamos et al. Endocrine Practice
- Ketoconazole in Cushing's Disease: Is It Worth a Try?
- (2014) Frederic Castinetti et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?
- (2014) Jennifer C. Stone et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The nuclear receptors COUP-TF: a long-lasting experience in forebrain assembly
- (2013) Christian Alfano et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Preincubation of Pituitary Tumor Cells With the Epidrugs Zebularine and Trichostatin A Are Permissive for Retinoic Acid-Augmented Expression of theBMP-4andD2RGenes
- (2013) Kiren Yacqub-Usman et al. ENDOCRINOLOGY
- Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature
- (2013) Gaëlle Quéreux et al. EXPERT OPINION ON PHARMACOTHERAPY
- Medical Treatment of Cushing's Disease
- (2013) Richard A. Feelders et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- LCI699, a Potent 11β-hydroxylase Inhibitor, Normalizes Urinary Cortisol in Patients With Cushing's Disease: Results From a Multicenter, Proof-of-Concept Study
- (2013) Xavier Bertagna et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- New avenues in the medical treatment of Cushing’s disease: corticotroph tumor targeted therapy
- (2013) Maria Fleseriu et al. JOURNAL OF NEURO-ONCOLOGY
- All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129
- (2013) Dan Douer et al. LEUKEMIA RESEARCH
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination therapy for Cushing’s disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?
- (2013) M. Barbot et al. Pituitary
- Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations
- (2013) Annamaria Colao et al. Pituitary
- Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease
- (2013) L. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New developments in the medical treatment of Cushing's syndrome
- (2012) R van der Pas et al. ENDOCRINE-RELATED CANCER
- Efficiency and tolerance of mitotane in Cushing's disease in 76 patients from a single center
- (2012) Camille Baudry et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- THERAPY IN ENDOCRINE DISEASE: Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review
- (2012) Veronica A Preda et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Potential Role for Retinoic Acid in Patients with Cushing's Disease
- (2012) Francesca Pecori Giraldi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome
- (2012) Maria Fleseriu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tretinoin and the Prevention of Keratinocyte Carcinoma (Basal and Squamous Cell Carcinoma of the Skin): A Veterans Affairs Randomized Chemoprevention Trial
- (2012) Martin A. Weinstock et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease
- (2012) Annamaria Colao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical management of Cushing’s disease: what is the future?
- (2012) Maria Fleseriu et al. Pituitary
- Somatostatin-Dopamine Chimeras: A Novel Approach to Treatment of Neuroendocrine Tumors
- (2011) M. Culler HORMONE AND METABOLIC RESEARCH
- EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
- (2011) Hidenori Fukuoka et al. JOURNAL OF CLINICAL INVESTIGATION
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor
- (2011) N.-A. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Bone Morphogenetic Protein (BMP) on Adrenocorticotropin Production by Pituitary Corticotrope Cells: Involvement of Up-Regulation of BMP Receptor Signaling by Somatostatin Analogs
- (2010) Naoko Tsukamoto et al. ENDOCRINOLOGY
- Cabergoline monotherapy in the long-term treatment of Cushing's disease
- (2010) Ariane Godbout et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Investigating gradients of gene expression involved in early human cortical development
- (2010) Bui K. Ip et al. JOURNAL OF ANATOMY
- Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Oscar Arrieta et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidemiology of Cushing’s Syndrome
- (2010) Charlotte Steffensen et al. NEUROENDOCRINOLOGY
- Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole
- (2010) Richard A. Feelders et al. NEUROENDOCRINOLOGY
- Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease
- (2010) Richard A. Feelders et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide for corticotroph pituitary adenomas refractory to standard therapy
- (2010) Troy H. Dillard et al. Pituitary
- Cushing's disease
- (2009) Xavier Bertagna et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
- (2009) Zhi Rong Qian et al. MODERN PATHOLOGY
- Immunohistochemistry of COUP-TFI: an adjuvant diagnostic tool for the identification of corticotroph microadenomas
- (2009) Zachary M. Bush et al. Pituitary
- Steroid Biosynthesis Inhibitors in the Therapy of Hypercortisolism: Theory and Practice
- (2008) P. Igaz et al. CURRENT MEDICINAL CHEMISTRY
- Overexpression of COUP-TF1 in murine embryonic stem cells reduces retinoic acid-associated growth arrest and increases extraembryonic endoderm gene expression
- (2008) Yong Zhuang et al. DIFFERENTIATION
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Differential regulation of human dopamine D2 and somatostatin receptor subtype expression by glucocorticoids in vitro
- (2008) C de Bruin et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas
- (2008) Marta Labeur et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started